FR16C0033I2 - Methode de formation de composes d'hydroxypyrone de fer - Google Patents

Methode de formation de composes d'hydroxypyrone de fer

Info

Publication number
FR16C0033I2
FR16C0033I2 FR16C0033C FR16C0033C FR16C0033I2 FR 16C0033 I2 FR16C0033 I2 FR 16C0033I2 FR 16C0033 C FR16C0033 C FR 16C0033C FR 16C0033 C FR16C0033 C FR 16C0033C FR 16C0033 I2 FR16C0033 I2 FR 16C0033I2
Authority
FR
France
Prior art keywords
formation
iron hydroxypyrone
hydroxypyrone compounds
iron
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR16C0033C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shield Tx UK Ltd
Original Assignee
Shield Tx UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shield Tx UK Ltd filed Critical Shield Tx UK Ltd
Publication of FR16C0033I1 publication Critical patent/FR16C0033I1/fr
Application granted granted Critical
Publication of FR16C0033I2 publication Critical patent/FR16C0033I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Iron (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR16C0033C 2002-05-18 2016-08-09 Methode de formation de composes d'hydroxypyrone de fer Active FR16C0033I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0211500.4A GB0211500D0 (en) 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds
PCT/GB2003/001956 WO2003097627A1 (fr) 2002-05-18 2003-05-07 Methode de formation de composes d'hydroxypyrone de fer

Publications (2)

Publication Number Publication Date
FR16C0033I1 FR16C0033I1 (fr) 2016-09-23
FR16C0033I2 true FR16C0033I2 (fr) 2018-01-19

Family

ID=9936987

Family Applications (1)

Application Number Title Priority Date Filing Date
FR16C0033C Active FR16C0033I2 (fr) 2002-05-18 2016-08-09 Methode de formation de composes d'hydroxypyrone de fer

Country Status (11)

Country Link
US (1) US7459569B2 (fr)
EP (1) EP1506183B1 (fr)
AT (1) ATE352547T1 (fr)
AU (1) AU2003233881A1 (fr)
BE (1) BE2016C041I2 (fr)
CA (1) CA2483067C (fr)
DE (1) DE60311456T2 (fr)
ES (1) ES2283771T3 (fr)
FR (1) FR16C0033I2 (fr)
GB (1) GB0211500D0 (fr)
WO (1) WO2003097627A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8952061B2 (en) * 2006-08-22 2015-02-10 University Of Virginia Patent Foundation Methods and compounds regulating the erythroid response to iron deficiency
HRP20150944T1 (hr) 2007-02-06 2015-10-09 Medical Research Council Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
EP3157516A4 (fr) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Compositions pharmaceutiques comprenant du citrate ferrique et procédés de fabrication de celles-ci
GB2531742B (en) * 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
WO2017167963A1 (fr) * 2016-03-31 2017-10-05 Medical Research Council Procédés de production de compositions de maltol ferrique à partir d'un hydroxyde ferrique modifié par un ligand et d'un hydroxyde ferrique recouvert d'un ligand
AU2017242905B2 (en) * 2016-03-31 2020-10-22 Shield TX (UK) Limited Methods for producing ferric maltol compositions from elemental iron
CA3019478C (fr) 2016-03-31 2024-02-13 United Kingdom Research And Innovation Compositions de maltol ferrique pour utilisation dans le traitement ou la prevention de tumeurs et de cancers
WO2017167970A1 (fr) * 2016-03-31 2017-10-05 Medical Research Council Procédés de production de compositions de maltol ferrique à partir d'hydroxydes ferreux
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CN112574158B (zh) * 2020-12-29 2022-08-02 南京百泽医药科技有限公司 一种麦芽酚铁晶型ii及其制备方法
CN115177625A (zh) * 2022-06-28 2022-10-14 金陵药业股份有限公司 一种羧基麦芽糖铁药用组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130204A (en) 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
DE1518098A1 (de) 1963-09-19 1969-04-10 Pfizer & Co C Verfahren zur Herstellung von Pyromekonsaeurederivaten
SE322866B (fr) 1966-12-15 1970-04-20 Astra Ab
US4018907A (en) 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4212685A (en) * 1978-12-11 1980-07-15 Lea Manufacturing Company Protective and color receptive coating for aluminum
US4279936A (en) 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
DK157856C (da) 1982-03-24 1990-07-30 Nat Res Dev Analogifremgangsmaade til fremstilling af et 3:1 hydroxypyridon:jern (iii)-kompleks
GR78491B (fr) 1982-03-24 1984-09-27 Nat Res Dev
EP0107458B1 (fr) 1982-10-22 1987-07-29 National Research Development Corporation Compositions pharmaceutiques
GB8308055D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308054D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8325496D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8329043D0 (en) 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8410289D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8606913D0 (en) 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
JPH0367565A (ja) 1989-08-07 1991-03-22 Kansai Paint Co Ltd 鉄分強化食品
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
AU6010696A (en) * 1995-06-10 1997-01-09 Vitra Pharmaceuticals Ltd Iron compounds, compositions, methods of making the same and uses thereof
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method

Also Published As

Publication number Publication date
AU2003233881A1 (en) 2003-12-02
US20050250754A1 (en) 2005-11-10
WO2003097627A1 (fr) 2003-11-27
EP1506183B1 (fr) 2007-01-24
US7459569B2 (en) 2008-12-02
CA2483067A1 (fr) 2003-11-27
DE60311456T2 (de) 2007-11-15
ATE352547T1 (de) 2007-02-15
CA2483067C (fr) 2011-04-26
GB0211500D0 (en) 2002-06-26
DE60311456D1 (de) 2007-03-15
BE2016C041I2 (fr) 2022-08-09
EP1506183A1 (fr) 2005-02-16
ES2283771T3 (es) 2007-11-01
FR16C0033I1 (fr) 2016-09-23

Similar Documents

Publication Publication Date Title
FR16C0033I2 (fr) Methode de formation de composes d'hydroxypyrone de fer
CY1108593T1 (el) Συμπυκνωμενο υδατικο διαλυμα αμβροξολης
BR0317696A (pt) Composição para branqueamento
TW200504058A (en) Method for preparing fused oxazinones
TR199902759T2 (xx) Sertindole �retimi i�in bir y�ntem
TR200100016T2 (tr) Hidroksimetiltiobütirik asitin hazırlanmasına yönelik metod
PL364087A1 (en) Method for the production of d-pantothenic acid and/or salts thereof as adjunct for animal feedstuffs
WO2004095921A3 (fr) Composition sporicide
PL365213A1 (en) Enteric ketoacid salts and amino acids
WO2002024001A3 (fr) Supplement alimentaire pour animaux contenant de l'acide d-pantothenique et/ou ses sels, procede ameliore permettant de le produire et son utilisation
EA200100095A1 (ru) Способ получения кальциевой соли зофеноприла
AU2002250978A1 (en) Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed
NO20001070D0 (no) Diureider og deres anvendelse
IT1291673B1 (it) Processo per la preparazione di 1,4,7,10 - tetraazaciclododecano
WO2002066663A3 (fr) Procede de production d'acide d-pantothenique et/ou de sels de celui-ci et utilisation de ces substances comme additifs dans des aliments pour animaux
EA200200783A2 (ru) Почвоулучшитель и средство для витализации воды
NZ334940A (en) process of producing 4-(des-dimethylamino)-tetracycline
ATE374764T1 (de) Basisches salz von thiooctansäure mitl-carnitin
AU2001249606A1 (en) Method of cyanide salt production
FR2816954B1 (fr) Solution aqueuse boree, realiser a partir d'un compose d'acide borique et de carbonate de sodium
WO2003051297A3 (fr) Composition d'ifosfamide aqueuse
WO2002061024A3 (fr) Composition
YU71302A (sh) Postupak za formiranje amidne veze
TR199902816T2 (xx) Geli�tirilmi� bir oral emilmesi ve biyolojik yararlan�m� olan bir HIV proteaz inhibit�r�n�n s�lfat tuzu.
PL353712A1 (en) Method of receiving calcium salt monohydrate of 2,5-dihydroxybenzenesulfonic acid